Geode Capital Management LLC Sells 3,773 Shares of LifeVantage Co. (NASDAQ:LFVN)

Geode Capital Management LLC lessened its stake in LifeVantage Co. (NASDAQ:LFVN) by 3.1% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 119,066 shares of the company’s stock after selling 3,773 shares during the quarter. Geode Capital Management LLC’s holdings in LifeVantage were worth $1,439,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Ritholtz Wealth Management grew its position in shares of LifeVantage by 62.0% during the 3rd quarter. Ritholtz Wealth Management now owns 28,666 shares of the company’s stock worth $346,000 after buying an additional 10,974 shares during the period. Barclays PLC raised its position in shares of LifeVantage by 38.2% in the 3rd quarter. Barclays PLC now owns 41,966 shares of the company’s stock valued at $507,000 after acquiring an additional 11,608 shares during the period. HighTower Advisors LLC bought a new position in LifeVantage during the 3rd quarter worth approximately $638,000. Capital Management Corp VA acquired a new position in LifeVantage during the third quarter valued at approximately $5,073,000. Finally, Renaissance Technologies LLC increased its stake in LifeVantage by 2.1% in the second quarter. Renaissance Technologies LLC now owns 855,118 shares of the company’s stock valued at $5,490,000 after purchasing an additional 17,300 shares in the last quarter. Institutional investors own 35.32% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Lake Street Capital began coverage on shares of LifeVantage in a research report on Thursday, December 19th. They set a “buy” rating and a $26.00 price target on the stock.

LifeVantage Trading Up 21.4 %

NASDAQ:LFVN opened at $19.97 on Friday. LifeVantage Co. has a 1 year low of $5.22 and a 1 year high of $24.00. The stock has a 50-day moving average price of $15.46 and a two-hundred day moving average price of $11.34. The stock has a market cap of $250.12 million, a price-to-earnings ratio of 62.41 and a beta of 0.82.

LifeVantage (NASDAQ:LFVN) last issued its quarterly earnings data on Tuesday, October 29th. The company reported $0.15 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.15. LifeVantage had a return on equity of 29.24% and a net margin of 2.11%. The business had revenue of $47.21 million during the quarter.

LifeVantage Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, December 16th. Stockholders of record on Monday, December 2nd were given a dividend of $0.04 per share. This represents a $0.16 annualized dividend and a dividend yield of 0.80%. The ex-dividend date of this dividend was Monday, December 2nd. LifeVantage’s dividend payout ratio is 50.00%.

About LifeVantage

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.